- ¿¬±¸°³¿ä
- Mitochondrial ion channel gene discovery
- ½ÉÀ庸ȣ±âÀü¿¡¼­ÀÇ ¹ÌÅäÄܵ帮¾Æ ÀÌ¿ÂÅë·ÎÀÇ ¿ªÇÒ ±Ô¸í
- Proteomics
- °ü»óµ¿¸Æ ÀÌ¿Âä³Î & ¹ÌÅäÄܵ帮¾Æ ÀÌ¿Âä³Î
- Chronic hypoxia
- Brugada syndrome
- õ¿¬¹°ÀÇ ¾àÈ¿¼ººÐ °ËÁõ ¹× ¸ÞÄ¿´ÏÁò
- ¹ÌÅäÄܵ帮¾Æ ÅëÇÕ ½É±Ù¼¼Æ÷ ¸ðµ¨ °³¹ß ¹æ¹ý
- »ýü¸ð»ç½Ã½ºÅÛ
- ¹ÌÅäÄܵ帮¾Æ Ÿ±ê ¾à¹°Àü´Þ½Ã½ºÅÛ
- ¹ÌÅäÄܵ帮¾ÆÀÇ »ý¸®
- ¹ÌÅäÄܵ帮¾Æ¿Í ÃãÀ»
- Patch Clamp Technique
- Imaging technique
- Proteomics
- e-Mitochondria
- Cellular Engineering
- Biomechanics
- Biomaterials
- BioMEMS
 
  • ¹ÌÅäÄܵ帮¾Æ »ýü½ÅÈ£ ±¹°¡ÁöÁ¤¿¬±¸½Ç
  • ¼¼Æ÷ ¹× »ýü¿ªÇÐ ±¹°¡ÁöÁ¤¿¬±¸½Ç
  • ¹ÌÅäÄܵ帮¾Æ ´Ü¹éÁú µ¥ÀÌÅͺ£À̽º
  • ÇãÇ÷¼º ½ÉÀåÁúȯ À¯ÀüÀÚ µ¥ÀÌÅͺ£À̽º (Ischemia)
Home > Center Introduction > ¿¬±¸³»¿ë > Chronic hypoxia
 
Chronic hypoxia
 
½ÉÇ÷°ü°è¿Í È£Èí±â°è´Â »ê¼ÒÀÇ Ç×»ó¼º À¯Áö¿¡ ÀÖ¾î Áß¿äÇÑ ±â´ÉÀ» ´ã´çÇÑ´Ù. Àú»ê¼Ò »óÅ¿¡¼­ ¼¼Æ÷´Â ¿©·¯ °¡Áö ´Ü¹éµéÀÌ º¯È­ÇÏ¿© »ý¸®ÀûÀÎ Çö»óÀ» ÀÏÀ¸Å°°Ô µÇ´Âµ¥, ¿©±â¿¡´Â hypoxia inducible factor-1 (HIF-1)¶ó´Â Àü»çÁ¶ÀýÀÎÀÚ°¡ °ü¿©ÇÏ¿© »ý¸®ÀûÀÎ ¹ÝÀÀÀ» Á¶ÀýÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ·¯ÇÑ Áß¿äÇÑ ±â´É ¶§¹®¿¡ Ä¡·áÇÐÀûÀ¸·Îµµ ¸Å¿ì Áß¿äÇÑ Àǹ̸¦ Áö´Ï°í ÀÖ´Ù.
ÇöÀç±îÁö ÁøÇàµÇ¾î ¿Â HIF-1¿¡ ´ëÇÑ ¸¹Àº ¿¬±¸µéÀº HIF-1ÀÌ Àú»ê¼ÒÁõ¿¡ ´ëÇÑ ¼¼Æ÷ÀÇ ÀÚ°¡Àû ȸº¹À̿ܿ¡µµ ¼¼Æ÷ÀÇ ´ë»ç(metabolism), Áõ½Ä(proliferation), »ýÁ¸(survival) µî¿¡ °ü¿©ÇÏ´Â À¯ÀüÀÚµéÀÇ È°¼º ¹× Á¶Àý¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ´Ù. ±× Áß¿¡¼­µµ, ÇöÀç ¸¹Àº ¿¬±¸ÀÚµéÀÌ °ü½ÉÀ» °¡Áö°í ¿¬±¸¸¦ Çϰí ÀÖ´Â °ÍÀÌ Á¾¾ç¿¡ ´ëÇÑ Ä¡·áÀûÀÎ Ãø¸é¿¡¼­ÀÇ HIF-1¿¬±¸ÀÌ´Ù. ÇÏÁö¸¸, ÀÌ·¯ÇÑ ¿¬±¸µéÀ» ½Ç½ÃÇϸ鼭 ÇöÀç±îÁö ÁøÇàµÇ¾î¿Â ½ÇÇèÀû ¹æ¹ýÀº ¸ðµÎ ÀÏÁ¤ÇÑ ½ÃÁ¡ÀÌ Áö³­ µÚ¿¡ ¼¼Æ÷¸¦ Á׿©¼­ °üÂûÇÏ´Â ¹æ¹ý(RT-PCR, Western blot, Immunocytochemistry µî)À» ÅëÇÑ °üÂûÀÌ ÁÖ¸¦ ÀÌ·ç¾î¿Ô´Ù.
ÀÌ·Î ÀÎÇØ, ½ÇÁ¦ÀûÀ¸·Î ¼¼Æ÷ ³»¿¡¼­ ÀÌ·ç¾îÁö´Â »ý¸®Àû½ÅÈ£¸¦ ½Ç½Ã°£(real time)À¸·Î °üÂûÇϰųª ¿¬¼ÓÀûÀÎ ¿øÀΰú °á°ú¸¦ µµÃâÇØ³»´Â µ¥¿¡´Â ±× ÇѰ踦 Áö´Ï°í ÀÖ´Ù. ÀÌ·¯ÇÑ ÇѰèÁ¡ µîÀÌ °á±¹ ÀÓ»ó ¸ðµ¨µ¿¹° ÅëÇÑ ½ÇÇèÀ¸·ÎÀÇ ¹ßÀüÀ» ´õµð°Ô ÇÏ´Â ¿äÀÎÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù.
 
º» ¿¬±¸¿¡¼­´Â, in vivo¿Í °¡Àå °¡±î¿î ÃÊ´ë¹è¾ç¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿© Ç¥ÀûÀ¯ÀüÀÚ³ª »ýü½ÅÈ£Àü´Þ¹°ÁúÀ» ¼¼Æ÷ ³»·Î À¯ÀÔ ½ÃÄÑ °¡½ÃÈ­Çϰí, ¼¼Æ÷°¡ ¿ÜºÎÀڱؿ¡ ´ëÇÏ¿© ¹ÝÀÀÇÏ´Â ½ÅÈ£Àü´ÞÀÇ ÀÏ·ÃÀÇ °úÁ¤À» ¼¼Æ÷°¡ »ì¾ÆÀÖ´Â »óÅ¿¡¼­ °üÂûÇÏ¿©, ±Ã±ØÀûÀ¸·Î´Â Á» ´õ Àӻ󿬱¸¿¡ °¡±î¿î ½ÇÇè¸ðµ¨À» °³¹ßÇÔÀ¸·Î½á, Àΰ£À¸·ÎÀÇ Ä¡·áÇÐÀû Àû¿ëÀ» ¾Õ´ç±â´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ´Ù.
 
Àú»ê¼ÒÁõ »óȲ¿¡¼­ HIF-1¿¡ ÀÇÇØ ¸Å°³µÇ´Â ÀÌ¿Âä³ÎÀÇ º¯È­¸¦ °üÂûÇÏ°í ±× ±âÀüÀ» ¹àÈ÷±â À§Çؼ­ ´ÙÀ½°ú °°Àº ´Ü°èÀûÀÎ ½ÇÇèÀýÂ÷¸¦ °ÉÄ£´Ù.
PRIMARY CELL CULTURE
µ¿¹°À̳ª »ç¶÷À¸·ÎºÎÅÍ ºÐ¸®µÈ Ç÷°ü ¹× ½ÉÀå¼¼Æ÷¸¦ ÃÊ´ë¹è¾ç(primary cell culture) ÇÑ´Ù(±×¸² 1).
°æ¿ì¿¡ µû¶ó¼­´Â, °¢ Àå±âÀ¯·¡ÀÇ ¼¼Æ÷ÁÖ
(¿¹, ½ÉÀå: H9c2, Ç÷°ü: BAEC µî)µµ º´¿ëÇÑ´Ù.
 
TRANSFECTION or VIRAL INFECTION
Çü±¤ ´Ü¹éÀ̳ª ¹ß»ö¹°ÁúÀ» À¶ÇÕ ½ÃŲ Ç¥ÀûÀ¯ÀüÀÚ¸¦ À¯ÀüÀÚ µµÀÔ¿ë ½Ã¾à(transfection reagent)À̳ª ¹ÙÀÌ·¯½ºÀÇ ¼¼Æ÷ ³» ħÀÔÀ» ÀÀ¿ëÇÑ À¯ÀüÀÚ µµÀÔ¿ë ¹ÙÀÌ·¯½º º¤ÅÍ(viral vector) µîÀ» ÀÌ¿ëÇÏ¿© ¼¼Æ÷ ³»·Î À¯ÀüÀÚµµÀÔ ÇÑ´Ù.
- HIF-1alpha¿Í GFP¸¦ À¶ÇÕ(fusion) ½ÃŲ ¹ßÇöº¤ÅÍ(expression vector)¸¦ ÃÊ´ëºÐ¸® ¹è¾çÇÑ ½É±Ù¼¼Æ÷(atrial myocytes)³ª Ç÷°ü¼¼Æ÷(vesicular smooth muscle cells or endothelial cells), ȤÀº ƯÁ¤Àå±âÀ¯·¡ÀÇ ¼¼Æ÷ÁÖ¿¡
<±×¸²1> Rat atrial myocytesÀÇ primary culture
±×¸² 3 Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¸¥ HIF-1alphaÀÇ ¹ßÇö°ú patch clamping transfection reagent(¿¹, FuGene6)¸¦ ÀÌ¿ëÇÏ¿© À¯ÀüÀÚµµÀÔÇϰí, G418À» ÇÔÀ¯ÇÑ ¹èÁö¸¦ ÅëÇØ ¼±Åà ¹è¾çÇÏ¿© ¿øÇÏ´Â ¼¼Æ÷ÁÖ(clones)¸¦ ¾ò¾î ³½´Ù.
<±×¸²2> »ê¼ÒÁõ¿¡ ÀÇÇÑ HIF-1alphaÀÇ ¹ßÇö°ú ÇÙ ³»·ÎÀÇ translocation È®ÀÎ
 
<±×¸²3> Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¸¥ HIF-1alphaÀÇ ¹ßÇö°ú patch clamping
 
CHARACTERIZATION
Imaging systemÀ» ÅëÇÏ¿© Ç¥ÀûÀ¯ÀüÀÚÀÇ ¹ßÇöÀ» È®ÀÎÇϰí, ¿ë¾×ÀÇ Á¶°ÇÀ̳ª ¾à¹°¹ÝÀÀÀ» ÁÖ¾î ÀÌ¿¡ µû¸¥ ¼¼Æ÷ ³» ½ÅÈ£ÀÇ º¯È­¸¦ ½Ç½Ã°£À¸·Î °üÂûÇÑ´Ù (±×¸²2, 3).
±× ¿¹ºñ °á°ú·Î¼­ 4-AP-sensitive K+ currents¸¦ Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¶ó °üÂûÇÏ¿´´Ù(±×¸² 4).
¿ë¾× ÁßÀÇ »ê¼ÒÀÇ ÇÔ·®À» 1%ÀÌÇÏ·Î ³·Ã߰ųª, HIF-1alphaÀÇ ¼¼Æ÷Áú ³» ºÐÇØ¸¦ Â÷´Ü½ÃŰ´Â ¾à¹°ÀÇ ÀÏÁ¾ÀÎ ciclopirox olamine (CPX)¸¦ óġÇÏ¿© HIF-1alphaÀÇ ÇÙ ³»·ÎÀÇ À̵¿°ú Ç¥ÀûÀ¯ÀüÀÚ Àü»çȰ¼º(transcription up-regulation)À» À¯µµÇϰí, RT-PCRÀ̳ª Ç¥ÀûÀ¯ÀüÀÚ tracing µîÀ» ÅëÇØ HIF-1¿¡ ÀÇÇÑ Ç¥ÀûÀ¯ÀüÀÚ Á¶Àý±âÀüÀ» È®ÀÎÇÑ´Ù. ÀÌ·¯ÇÑ mRNA screeningÀÇ Ç¥ÀûÀ¯ÀüÀڷμ­´Â ¸¸¼º Àú»ê¼ÒÁõ »óȲ¿¡¼­ Ȱ¼ºÈ­µÇ´Â channel protein, apoptosis ¶Ç´Â Á¾¾çÇü¼º¿¡ °ü¿©ÇÏ´Â Èĺ¸À¯ÀüÀÚ µîÀ» ±× ´ë»óÀ¸·Î ÇÑ´Ù.
 
MODELING or DEVELOPMENT
À§ÀÇ ½ÇÇèÀ» ¹ÙÅÁÀ¸·Î in vivo model (transgenic ¶Ç´Â knock-out/down animal)À» ¼³°è/°³¹ßÇÏ¿© º¸´Ù È¿°úÀûÀ̰í À¯¿ëÇÑ ÀÓ»ó½ÇÇèÀ» ½Ç½ÃÇÑ´Ù.
- Àú»ê¼ÒÁõ¿¡ ´ëÇÏ¿© sensor¿ªÇÒÀ» ´ã´çÇϴ ä³Î´Ü¹éÀ» ¹àÈ÷°í, À̰ÍÀÇ ±â´ÉÀ» °á¼Õ ½ÃŲ µ¿¹°¸ðµ¨À» °³¹ßÇÏ¿©,
  Àú»ê¼Ò¼º Áúȯ¿¡ ´ëÇÑ Ä¡·áÁ¦ÀÇ °³¹ß¿¡ ÀÀ¿ëÇÑ´Ù.
- Á¾¾ç°ú °ü·ÃÇÏ¿© ¼¼Æ÷»ç ±âÀü¿¡ °áÁ¤ÀûÀÎ ¿ªÇÒÀ» ´ã´çÇÏ´Â ¼¼Æ÷ ³» moleculeÀÇ ½ÅÈ£Àü´Þ°úÁ¤À» ±Ô¸íÇϰí, ÀÌ·¯ÇÑ
  moleculeÀÇ È°¼ºÀ» Á¶ÀýÇÏ´Â À¯ÀüÀÚ¸¦ ¹ÙÅÁÀ¸·Î Á¦ÀÛµÈ ¸ðµ¨µ¿¹°ÀÇ ½ÇÇèÀ» ÅëÇØ Á¾¾çÇü¼º¿¡ ÀúÇ×¼ºÀ» ³ªÅ¸³»´Â
  À¯ÀüÀû ÇüÁúÀ» ±Ô¸íÇϰí Á¾¾ç¿¹¹æ ¹× Ä¡·á¿¡ Ȱ¿ëÇÑ´Ù.
<±×¸²4> H9c2 ¼¼Æ÷ÁÖÀÇ Àú»ê¼ÒÁõ¿¡ µû¸¥ 4-AP-sensitive K+ currentsÀÇ ½Ã°£Àû º¯È­ °üÂû
 
Archer SL, Weir EK, Reeve HL, Michelakis E. Molecular identification of O©÷ sensors and O©÷-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol. 2000;475:219-40. Review
Liu Y, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol. 2002 Apr;29 (4):305-11. Review
Perez-Garcia MT, Lopez-Lopez JR. Are Kv channels the essence of O©÷ sensing? Circ Res. 2000 Mar 17;86(5):490-1. Review.
Standen NB, Quayle JM. K+ channel modulation in arterial smooth muscle. Acta Physiol Scand. 1998 Dec;164 (4):549-57. Review
Sweeney M, Yuan JX. Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels. Respir Res. 2000;1(1):40 -8. Epub 2000 Jul 3. Review
Yuan XJ, Tod ML, Rubin LJ, Blaustein MP. Hypoxic and metabolic regulation of voltage-gated K+ channels in rat pulmonary artery smooth muscle cells. Exp Physiol. 1995 Sep;80 (5):803-13. Review.
 
Mitochondrial Signaling Laboratory
Research Interests Members Publication Seminar Community Sitemap Contact Webmail
 
À§·Î